pharma news today obesity drugs glp-1 today Chart: 1 in 8 Americans Now Use for Weight Loss GLP-1 drugs transform obesity care,

GIP may add further support for insulin response, metabolism, and how the body manages fat

A study involving 966 patients on statins during exenatide trials found that lipid-lowering effects were comparable to those in the placebo group 51% were on atorvastatin, and 31% on simvastatin

K.SanchezM.MickelC.Williams-HermanD

A methodological framework for meta-analysis and clinical interpretation of subgroup data: the case of major adverse cardiovascular events with GLP-1 receptor agonists and SGLT2 inhibitors in type 2 diabetes

Bezin, J., Gouverneur, A., Penichon, M., Mathieu, C., Garrel, R., Hillaire-Buys, D., Pariente, A., & Faillie, J